SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dipna Pharmachem informs about updates

02 Apr 2024 Evaluate
Dipna Pharmachem has informed that Dipna Pharmachem has received Sales order of Rs 12.75 Crores from the Fact trading Co., Morbi to deliver Melamine powder and marks a significant step forward in our business growth. The details required under Regulation 30 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 09/09/2015 is enclosed as Anexure-1.

The above information is a part of company’s filings submitted to BSE.

Dipna Pharma. Share Price

8.20 -0.11 (-1.32%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 222.80
Adani Enterprises 2505.65
Amrapali Industries 18.21
Rashi Peripheral 530.50
PDS 300.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×